Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Robinsons Bank to open more branches

2018-07-03 bworldonline
ROBINSONS BANK Corp. is set to open more branches this year as it intends to expand its market reach.
RBNTF RRETY RRHI

4
Robinsons Bank raising P5B via debt market

2018-06-28 business.inquirer.net
Gokongwei-led Robinsons Bank has returned to the local debt market with an offering of as much as P5 billion worth of high-yielding deposits, proceeds from which will fund the bank’s aspiration to becoming one of the country’s leading banks.
JGSMY JGS RBNTF RRETY JGSHF RRHI

4
Robinsons Bank offering LTNCDs

2018-06-28 bworldonline
ROBINSONS BANK Corp. has started its offer of long-term negotiable certificates of deposit (LTNCD), which it plans to list on July 16.
JGSMY JGS RBNTF RRETY JGSHF RRHI

0
Muntinlupa taps PayMaya for citizen card

2018-05-29 bworldonline
PAYMAYA Philippines, Inc. has partnered with the local government unit (LGU) of Muntinlupa for cashless transactions through the expanded care card for the city’s residents.
RBNTF RRETY RRHI

7
JG Summit to ramp up capital spending this year

2018-05-29 bworldonline
JG SUMMIT Holdings, Inc. is hiking its capital spending for 2018 as it aims to grow its petrochemical, airline, property, food and beverage, and banking businesses amid higher oil prices in the world market and the further depreciation of the peso.
JGSMY JGS RBNTF CEBUY UVRBY RBLAY CEBUF RLC RRETY URC CEB JGSHF UVRBF RRHI

0
Muntinlupa LGU launches ‘care card’ that can be used for cashless transactions

2018-05-29 bworldonline
PayMaya Philippines has partnered with the local government unit (LGU) of Muntinlupa to launch a card that the city’s residents can use to receive cash benefits and make cashless transactions.
RBNTF RRETY RRHI

0
RRHI brings Singaporean pet store franchise to PH

2018-05-29 business.inquirer.net
Gokongwei-led retailer Robinsons Retail Holdings Inc. (RRHI) has entered pet care retailing through a franchise agreement with Pet Lovers Centre, Singapore’s leading pet store operator.
RBNTF RRETY RRHI

5
Robinsons Bank sets P3B capital hike

2018-05-29 business.inquirer.net
The Gokongwei group seeks to make commercial banking arm Robinsons Bank a more significant player in the banking arena with the infusion of P3 billion in fresh capital by July.
JGSMY JGS RBNTF RRETY JGSHF RRHI

5
RRHI to spend up to P3.5 billion for store expansion

2018-05-28 bworldonline
ROBINSONS Retail Holdings, Inc. (RRHI) will be spending up to P3.5 billion in capital expenditures this year to support its development of 100 to 120 new stores.
DFIHY PSKXF RBNTF RRETY PHSXY PSE DFILF RRHI

5
Stocks end flat on lack of leads, US-North Korea

2018-05-28 bworldonline
THE MAIN INDEX closed flat on Monday due to a lack of leads, alongside muted trading overseas.
PSKXF RBNTF NOW RRETY PHSXY PSE BBRRF BLOOM DNOW RRHI

5
Share prices barely move on lack of leads

2018-05-28 bworldonline
The main index closed flat on Monday, May 28, due to lack of leads alongside muted trading overseas.
PSKXF RBNTF NOW RRETY PHSXY PSE BBRRF BLOOM DNOW RRHI

0
Robinsons Retail (RRETY) Presents At 6th Annual Philippines Owners Access Conference - Slideshow

2018-05-17 seekingalpha
The following slide deck was published by Robinsons Retail Holdings Inc. ADR in conjunction with this event.
RBNTF RRETY RRHI

5
Puregold exits convenience store sector, sells stake in Lawson

2018-04-27 business.inquirer.net
Retail magnate Lucio Co-led Puregold Price Club Inc. is bowing out of the convenience store business three years after debuting into this highly competitive segment, choosing to focus on the battleground for supermarkets.
PSKXF RBNTF RRETY SEVN PHSXY PSE PHSVY RRHI

4
Robinsons Place Ormoc’s opening draws big crowd

2018-04-27 lifestyle.inquirer.net
Ormoc board member Mesias Arevalo, Robinsons Land Corp. (RLC) president Frederick D. Go, RLC celebrity endorser Maja Salvador, RLC SVP/GM Arlene G. Magtibay, Robinsons Retail Holdings president Robina Gokongwei-Pe, Ormoc City Mayor Richard Gomez, Vice Mayor Toto Locsin Jr.
RLC RBNTF RRETY SYBJF RBLAY SECB RRHI

23
Stock price index pulls back to 7,500

2018-04-25 business.inquirer.net
The local stock barometer pulled back to the 7,500 level on Wednesday, weighed down by local currency jitters and the downturn across US and regional markets.
SVTMF PSKXF RBNTF BDOUY AYAAY SM BDOUF BDO SMIVY ALGGY RRETY ALGGF PHSXY PSE AGI ALI AYAAF RRHI

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 771007101